⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

Official Title: A Prospective, Longitudinal, Observational Study in Newly Diagnosed Multiple Myeloma (MM) Patients to Assess the Relationship Between Patient Outcomes, Treatment Regimens and Molecular Profiles

Study ID: NCT01454297

Interventions

Study Description

Brief Summary: The primary objective of this observational study is to identify the molecular profiles and clinical characteristics that define subsets of myeloma patients during the course of the disease.

Detailed Description: Understanding the molecular basis of cancer is a critical step toward devising the most effective treatment of the patient as an individual. The promise of molecular targeted therapeutics and personalized cancer care has been demonstrated in breast and lung cancer and chronic myeloid leukemia. However, similar examples of success in multiple myeloma have not been achieved despite extensive basic research as well as clinical advances. What is well understood is that myeloma is a heterogeneous disease with great genetic and epigenetic complexity.22, 23 Therefore, there remains a critical need to understand myeloma patient biology in the context of current patient care.24 The objective of this longitudinal study is to identify patient subgroups and phenotypes defined by molecular profiling and clinical features. These profiles will enable a better understanding of mechanisms of disease, drug response and patient relapse. Ultimately the study is intended to drive successful drug development and patient care in multiple myeloma.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Mayo Clinic Campus in Scottsdale, AZ, Scottsdale, Arizona, United States

UC San Diego Moores Cancer Center, San Diego, California, United States

Sharp Health Care, San Diego, California, United States

VA San Diego Healthcare System, San Diego, California, United States

San Francisco VA Medical Center, San Francisco, California, United States

UCSF Medical Center, San Francisco, California, United States

Kaiser Permanente of Colorado, Denver, Colorado, United States

Rocky Mountain Cancer Centers, Denver, Colorado, United States

Carl and Dorothy Bennett Cancer Center, Stamford, Connecticut, United States

VA Medical Center, Washington DC,, Washington, District of Columbia, United States

Ocala Oncology Center, Ocala, Florida, United States

Winship Cancer Institute - Emory University, Atlanta, Georgia, United States

Atlanta VA Medical Center, Decatur, Georgia, United States

University of Chicago, Chicago, Illinois, United States

Illinois Cancer Specialists, Niles, Illinois, United States

Cancer Center of Kansas, Wichita, Kansas, United States

Peninsula Regional Cancer Center, Salisbury, Maryland, United States

Holy Cross Hospital, Silver Spring, Maryland, United States

Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States

Grand Rapids Clinical Oncology Program, Grand Rapids, Michigan, United States

Mayo Clinic-Rochester, Rochester, Minnesota, United States

University of Mississippi Medical Center, Jackson, Mississippi, United States

Kansas City VA Medical Center, Kansas City, Missouri, United States

Washington University, Saint Louis, Missouri, United States

Billings Clinic, Billings, Montana, United States

University of Nebraska Medical Center, Omaha, Nebraska, United States

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Hackensack University Medical Center, Hackensack, New Jersey, United States

Saint Barnabas Medical Center, Livingston, New Jersey, United States

Eastchester Center for Cancer Care, Bronx, New York, United States

Broome Oncology, Johnson City, New York, United States

New York University Medical Center, New York, New York, United States

Mt Sinai Medical Center, New York, New York, United States

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Weill Cornell Medical College-NY Presbyterian Hospital, New York, New York, United States

St Francis Hospital, Roslyn, New York, United States

Waverly Hematology Oncology, Cary, North Carolina, United States

Levine Cancer Institute, Charlotte, North Carolina, United States

Duke University Hospital, Durham, North Carolina, United States

East Carolina University, Greenville, North Carolina, United States

First Health Outpatient Cancer Center, Pinehurst, North Carolina, United States

Ohio State University Wexner Medical Center, Columbus, Ohio, United States

Oregon Health and Science University, Portland, Oregon, United States

Northwest Cancer Specialists, PC, Tualatin, Oregon, United States

Sarah Cannon Research Institute, Nashville, Tennessee, United States

Baylor Research Institute, Dallas, Texas, United States

University of Texas Southwest Medical Center, Dallas, Texas, United States

Cancer Care Centers of South Texas, San Antonio, Texas, United States

Central Texas VA Healthcare Center, Temple, Texas, United States

Texas Oncology - Tyler, Tyler, Texas, United States

Texas Oncology- Waco, Waco, Texas, United States

Virginia Cancer Specialists PV, Fairfax, Virginia, United States

Cancer Care Northwest, Spokane, Washington, United States

Yakima Valley Memorial Hospital/North Star Lodge, Yakima, Washington, United States

Marshfield Clinic, Marshfield, Wisconsin, United States

Tom Baker Cancer Centre, Alberta Health Services, Calgary, Alberta, Canada

Cross Cancer Institute, Alberta Health Services, Edmonton, Alberta, Canada

Princess Margaret Cancer Centre, Toronto, Ontario, Canada

McGill University Health Center, Royal Victoria Hospital, Montreal, Quebec, Canada

Hospital Clinica Universitari Lozano Blesa, Zaragoza, Aragón, Spain

Hospital University de Salamanca, Salamanca, Castilla-León, Spain

H. U. Germans Trias i Pujol, Badalona, Cataluña, Spain

Hospital Univ Son Espases, Palma de Mallorca, Islas Baleares, Spain

Hospital Son Llàtze, Palma de Mallorca, Islas Baleares, Spain

Hospital Quirón de Madrid, Pozuelo de Alarcón, Madrid, Spain

University Hospital Infanta Sofia, San Sebastián de los Reyes, Madrid, Spain

Clínica Universitaria de Navarra, Pamplona, Navarra, Spain

Hospital Universitari de Canarias, Tenerife, Santa Cruz, Spain

Hospital del Mar, Barcelona, , Spain

Hospital Santa Creu I Sant Pau, Barcelona, , Spain

Hospital Clinic i Provincial, Barcelona, , Spain

Hospital Ramón y Cajal, Madrid, , Spain

Hospital Puerta de Hierro, Madrid, , Spain

Contact Details

Name: Daniel Auclair

Affiliation: Multiple Myeloma Research Foundation

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: